Transforming Development to Deliver 21st Century Clinical Trials
Pfizer is working to seamlessly integrate clinical trials into the lives of patients through the use of mobile and digital technologies, from electronic consent forms to wearables that enable remote collection of clinical data, as well as collaborations with large health systems. We participate and lead in collaborations such as TransCelerate, the Clinical Trials Transformation Initiative, and the Innovative Medicines Initiative to share best practices and develop shared solutions. We are also engaged in multiple innovative partnerships that apply digital and artificial intelligence (AI) tools to reduce trial time, design more efficient studies, and drive greater access to clinical trials for diverse populations.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families